Erica Ullman

5PUBLICATIONS
90CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 31, 2024
A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants.

Yan Yang, Avvaru N Suhasini, Zaoli Jiang

|Nov 09, 2022
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models.

Joyce Wei, Welby Montalvo-Ortiz, Lola Yu

|Jun 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy.

Janelle C Waite, Bei Wang, Lauric Haber

|Jun 17, 2020
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.

Johanna Hansen, Alina Baum, Kristen E Pascal

|Jan 10, 2020
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies.

Dimitris Skokos, Janelle C Waite, Lauric Haber

Pageof 1

Frequent Collaborators

5 joint publications

William Olson

4 joint publications

Andrew J Murphy

4 joint publications

Aynur Hermann

4 joint publications

Ashique Rafique